Pfizer More: Pfizer announces approval by the China Food And Drug Administration Of XELJANZ, the first oral JAK inhibitor for adult patients with moderately to severely active rheumatoid arthritis Source: MDlinx
read moreMarathon, under heavy fire for Emflaza pricing, makes surprise deal to sell drug for $140M-plus esagonowsky Thu, 03/16/2017 – 10:48 More: Marathon, under heavy fire for Emflaza pricing, makes surprise deal to sell drug for 0M-plus Source: fierce
read moreFDA warns of pancreatitis deaths from treatment with Allergan’s IBS-D med Viberzi chelfand Thu, 03/16/2017 – 10:16 More: FDA warns of pancreatitis deaths from treatment with Allergan's IBS-D med Viberzi Source: fierce
read moreFDA details problems at Pfizer plant that derailed generic Copaxone approval epalmer Thu, 03/16/2017 – 10:16 More: FDA details problems at Pfizer plant that derailed generic Copaxone approval Source: fierce
read moreAllergan, Teva claim top spots in GAAP vs. non-GAAP hall of shame: report arlene.weintraub Thu, 03/16/2017 – 09:26 More: Allergan, Teva claim top spots in GAAP vs. non-GAAP hall of shame: report Source: fierce
read moreMylan extends recall as stray tablets of diabetes med show up in bottles of an antidepressant epalmer Thu, 03/16/2017 – 09:07 More: Mylan extends recall as stray tablets of diabetes med show up in bottles of an antidepressant Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals